Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |